The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer.
To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk.
To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.
Memphis, Tennessee 38105, United States
SJLIFE participant and 22 years of age or older at time of enrollment
Participant or legal guardian is able and willing to give informed consent
At least 5 years after childhood cancer diagnosis
Been diagnosed with cardiomyopathy on previous SJLIFE ECG
Currently on heart medication
Study Contact Info
Contact Listings Owner Form
An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks 0 reviewsWrite Your Review
There are no reviews yet.